In the unfolded protein response (UPR), protein-folding stress in the endoplasmic reticulum (ER) activates a large transcriptional program to increase ER folding capacity. During the budding yeast UPR, the trans-ER-membrane kinase-endoribonuclease Ire1 excises an intron from the HAC1 mRNA and the exon cleavage products are ligated and translated to a transcription factor that induces hundreds of stress-response genes. HAC1 cleavage by Ire1 is thought to be the rate limiting step of its processing. Using cells with mutations in RNA repair and decay enzymes, we show that phosphorylation of two different HAC1 splicing intermediates by Trl1 RNA 5′-kinase is required for their degradation by the 5′→3′ exonuclease Xrn1 to enact opposing effects on the UPR. Kinase-mediated decay (KMD) of cleaved HAC1 3′-exon competes with its ligation to limit productive splicing and suppress the UPR, whereas KMD of the excised intron activates HAC1 translation, likely by relieving an inhibitory base-pairing interaction between the intron and 5′-untranslated region. We also found that ligated but 2′-phosphorylated HAC1 mRNA is endonucleolytically cleaved, yielding a KMD intermediate with both 5′-and 2′-phosphates at its 5′-end that inhibit 5′→3′ decay, and suggesting that Ire1 initiates the degradation of incompletely processed HAC1 s to proofread ligation or attenuate the UPR. These multiple decay events expand the scope of RNA-based regulation in the budding yeast UPR and may have implications for the control of the metazoan UPR by mRNA processing.
INTRODUCTION
During the unfolded protein response (UPR), protein folding stress in the lumen of the endoplasmic reticulum leads to oligomerization of the transmembrane kinase/endoribonuclease Ire1 and the processing of a cytoplasmic mRNA to yield splicing intermediates with 2′,3′-cyclic phosphate (PO 4 ) and 5′-hydroxyl (OH) termini (Gonzalez et al., 1999) . In budding yeast, excision of an intron from the HAC1 u mRNA (" u " denoting the u nspliced mRNA) by Ire1 is followed by exon ligation by the multifunctional Trl1 RNA ligase (Sidrauski et al., 1996) involving 5′-phosphorylation of the 5′-OH product, adenylylation of the 5′-PO 4 , and resolution of the 2′,3′-cyclic PO 4 to a 2′-PO 4 /3′-OH. The newly produced 3′-OH serves as the nucleophile to attack the 5′-adenylate intermediate, yielding a ligated mRNA with an internal 2′-PO 4 . The 2′-PO 4 is removed in a separate reaction by the 2′-phosphotransferase, Tpt1, in a NAD-dependent reaction (Culver et al., 1997) . The spliced mRNA, called HAC1 s mRNA (" s " denoting s pliced mRNA) (Li et al., 2018) , is translated into a transcription factor that activates the expression of hundreds of stress-response genes to mitigate protein-folding stress (Ron and Walter, 2007) . In addition, Hac1 activates its own promoter in a positive feedback loop that generates more HAC1 u and permits sustained UPR activation (Ogawa and Mori, 2004) ( Fig. 1A ).
Control of this positive feedback loop ensures UPR suppression during normal growth and rapid activation upon stress exposure. To facilitate the control of UPR activation, HAC1 u contains cis -regulatory elements that suppress unintended translation and promote rapid processing. If a ribosome initiates on HAC1 u , translation through the 5′-exon/intron junction yields a truncated protein with an intron-encoded C-terminal peptide "degron" that targets it for ubiquitylation and degradation (Di Santo et al., 2016) . A stem-loop in its 3′-untranslated region (the "3′-BE") tethers HAC1 u to the ER membrane, ensuring rapid Ire1-mediated cleavage following ER stress (Aragón et al., 2009 ) . Finally, a long-range base-pairing interaction between the 5′-UTR and intron prevents ribosome initiation to suppress translation of HAC1 u mRNA (Chapman and Walter, 1997; Di Santo et al., 2016) .
Previous work found unexpected roles for RNA decay and repair enzymes acting on HAC1 mRNA in the budding yeast unfolded protein response. Ire1 is a metal-ion-independent endonuclease that produces RNA cleavage products with 5′-OH termini (Gonzalez et al., 1999) .
In cells lacking the cytoplasmic 5′→3′ exonuclease Xrn1, HAC1 splicing intermediates accumulate with 5′-PO 4 termini, indicating that an RNA 5′-kinase phosphorylates HAC1 processing intermediates and that not all HAC1 splicing intermediates are productively ligated (Harigaya and Parker, 2012; Peach et al., 2015) . In addition to its role in HAC1 exon ligation, Trl1 is required to relieve translational attenuation of HAC1 s by an unknown mechanism (Mori et al., 2010) . In cells expressing the T4 bacteriophage RNA repair enzymes PNK and RNL in lieu of TRL1 , ligated HAC1 molecules contained single nucleotide deletions from the 3′-terminus of the 5′-exon, indicating that a 3′→5′ exonucleolytic activity acts on the cleaved 5′-exon (Schwer et al., 2004) and nuclear decay of HAC1 u liberates the 3′-BE, tuning the activation potential of the UPR (Sarkar et al., 2018) .
Recent studies showed that RNA decay also plays a role in the UPR in other organisms.
During UPR activation in the fission yeast, Ire1 incises specific mRNAs to promote their stabilization or degradation (Guydosh et al., 2017; Kimmig et al., 2012) . This mode of Ire1 cleavage is similar to the metazoan Regulated Ire1-Dependent Decay (RIDD) pathway wherein Ire1 incises ER-localized mRNAs and the cleavage products are degraded by Xrn1 and the cytoplasmic exosome (Hollien and Weissman, 2006) .
Here, we used budding yeast with mutations in RNA repair and decay enzymes to show that HAC1 splicing intermediates are processed at multiple steps prior to ligation, limiting the impact of spurious Ire1 activation and unintentional HAC1 cleavage. Our studies also show that incompletely spliced HAC1 s mRNA is targeted for degradation, which may be used to attenuate the UPR.
RESULTS
RNA repair mutants have unique HAC1 mRNA processing defects.
We recently showed that the functions of the essential RNA repair enzymes Trl1 and Tpt1 in budding yeast can be genetically bypassed by the expression of intronless tRNAs, which are able to support translation in trl1∆ and tpt1∆ cells (Cherry et al., 2018) . Because Trl1 is required for HAC1 s ligation and subsequent UPR activation (Sidrauski et al., 1996) , trl1 ∆ cells are unable to grow on media containing tunicamycin ( Fig. 1B ) . In contrast, the general growth defect of tpt1 ∆ cells is unaffected by tunicamycin (Cherry et al., 2018) ( Fig. 1B ) , indicating that these cells can activate the UPR. Combination of trl1∆ and tpt1∆ with mutations in 5′→3′ and 3′→5′ decay factors xrn1∆ or ski2∆ led to more pronounced growth defects than the single deletions, but removal of these decay factors did not affect the growth deficit of trl1∆ or tpt1∆ cells on tunicamycin ( Fig. 1B ) .
Given the multiple enzymatic roles of Trl1 and Tpt1 during RNA repair, we sought to understand how the loss of these enzymes affected HAC1 mRNA splicing. We visualized HAC1 splicing intermediates by northern blotting with probes for the HAC1 3′-exon and intron ( Fig. 1C , D ) and found robust cleavage and ligation of HAC1 u in wild-type cells in the presence of tunicamycin, leading to high levels of HAC1 s . As expected, trl1 ∆ cells lacking RNA ligase activity did not produce HAC1 s upon tunicamycin treatment. However, cleaved 3′-exon and intron accumulated upon tunicamycin treatment in trl1 ∆ cells ( Fig. 1C, D ) , indicating a defect in 3′-exon decay. Cleaved HAC1 3′-exon often appears as a smear of products between~450 nt and~575 nt ( Fig. 1C , lanes 4-8); we attribute this size heterogeneity to differences in poly(A) tail presence or length, as the 5′-ends of these products occur uniformly at one site ( Fig. 5A ).
The 2′-phosphotransferase Tpt1 is essential in budding yeast to remove 2′-phosphate groups from ligated tRNAs (Culver et al., 1997) , but its role in HAC1 mRNA processing during the UPR has not been defined. Although the growth of tpt1 ∆ cells is unaffected by tunicamycin ( Fig. 1B ), specific perturbations of HAC1 processing in tpt1∆ cells indicate that residual 2′-phosphate groups on HAC1 mRNA cause defects in cleavage and ligation. Whereas tunicamycin treatment led to cleavage of HAC1 u and production of HAC1 s in tpt1∆ cells, the levels of HAC1 s ( Fig. 1C ) and excised intron ( Fig. 1D ) are significantly lower than in wild-type cells. In addition, despite the fact that tpt1 ∆ cells have functional RNA ligase, cleaved 3′-exon accumulated to high levels upon tunicamycin treatment ( Fig. 1C , lane 6).
Kinase-mediated decay of cleaved HAC1 3′-exon competes with its ligation.
To further investigate the 3′-exon decay defect, we examined splicing of HAC1 in xrn1 ∆ cells. We found that HAC1 s accumulated in the absence of tunicamycin ( Figs. 1C, 2A, C, and D, lanes 3 and 4; 2E, lane 5). This promiscuous processing was surprising given that HAC1 s is undetectable in wild-type cells under normal growth conditions, and it suggested that Xrn1 somehow limits production of HAC1 s . In xrn1∆ cells, 3′-exon accumulated to modest levels in both the absence and presence of tunicamycin ( Fig. 2A, lanes 3 and 4) , whereas in trl1∆ cells, HAC1 3′-exon accumulated to higher levels ( Fig. 2A , lane 6; 2B, lane 4). Moreover, the abundance of 3′-exon was similar in trl1 ∆ and trl1∆ xrn1∆ cells ( Fig. 2A ), indicating that Xrn1 requires Trl1 for 3′-exon degradation. Previous work showed that Trl1 5′-kinase activity is required for the Xrn1-mediated degradation of excised tRNA introns in budding yeast (Wu and Hopper, 2014) , and we considered whether this pathway also degraded HAC1 3′-exon. Indeed, expression of a kinase-inactive version of Trl1 (Trl1-D425N) (Wang et al., 2006) did not restore Cherry et al .
Xrn1-mediated decay of the 3′-exon ( Fig. 2B , lanes 5-8), affirming that Trl1 ligase 5′-kinase activity is required for Xrn1-mediated suppression of HAC1 splicing. We also examined the accumulation of 3′-exon in cells lacking Dxo1, a distributive, 5′-phosphate-dependent, 5′→3′
exonuclease (Chang et al., 2012) , and found that HAC1 3′-exon accumulation was unaffected in dxo1 ∆ cells . In addition, the levels of 3′-exon were similar in xrn1 ∆ and dxo1∆ xrn1∆ cells ( Fig.   2C ), indicating that Xrn1 is the primary factor responsible for 5′→3′ decay of the 3′-exon.
Together these data indicate that ligation and Xrn1-mediated 5′→3′ decay compete for the 5′-phosphorylated 3′-exon splicing intermediate ( Fig. 2F , top (Chakravarty et al., 2012) . We found that upon tunicamycin treatment, HAC1 s was produced in trl1∆ (RtcB) cells ( Fig. 2D , lanes 6 and 8), as shown previously (Tanaka et al., 2011 3′-exon appears to counteract a low rate of background Ire1 cleavage to ensure the UPR is only activated when legitimately stimulated.
Kinase-mediated decay of excised intron is required for HAC1 s translation.
In several instances, cells with mutations in repair and decay factors can splice HAC1 but fail to grow on media containing tunicamycin ( Fig. 3A ), indicating that HAC1 s production is not sufficient to activate the UPR. We assayed expression of KAR2 , an ER chaperone and direct target of the Hac1 transcription factor (Kohno et al., 1993) , and found that all repair and decay mutants express significantly less KAR2 mRNA upon tunicamycin treatment ( Fig. 3B ), consistent with another layer of UPR regulation downstream of HAC1 s production. Excised HAC1 intron accumulates upon tunicamycin treatment in trl1∆, xrn1∆, and trl1∆ xrn1∆ cells ( Fig.   3C ). Moreover, the intron decay products that accumulate in these cells are indicative of kinase-mediated decay: in xrn1∆ cells that lack Xrn1 but have 5′-kinase activity, intron products appear with a few distinct, smaller products below the full-length 252 nt excised intron ( Fig. 3C , lanes 3 and 4). In contrast, excised intron accumulated as a uniform,~250 nt product in trl1∆ cells that lack 5′-kinase activity ( Fig. 3C , lanes 5-8), independent of XRN1 status. Moreover, production of shorter decay products (like those present in xrn1∆ cells) was dependent on Trl1 5′-kinase catalytic activity ( Fig. 3D ). Together, these data show that excised HAC1 intron is a substrate for kinase-mediated decay with strict dependence on a 5′-phosphorylation step to promote 5′→3′ decay.
A single deletion of Dxo1 had no effect on HAC1 intron degradation ( Fig. 3E , lanes 2 and 6); however, the sizes of smaller decay products in xrn1∆ dxo1∆ cells were subtly different than in xrn1 ∆ cells ( Fig. 3E, lanes 4 and 8) , indicating that Dxo1 and other exonucleases partially degrade excised HAC1 intron, but only when it accumulates in xrn1∆ cells. Consistent with this notion, we found that the cytoplasmic exosome also contributes to HAC1 intron turnover ( Fig. 3H ), but this mode of decay is unlikely to regulate the UPR as the growth of ski2∆ cells is unaffected by tunicamycin ( Fig. 1B ).
In trl1∆ (RtcB) cells, excised HAC1 intron accumulates as a circle, evinced by its altered mobility and resistance to Xrn1-mediated decay in vivo ( Fig. 3F , lanes 5-8), and its resistance to RNase R degradation in vitro ( Fig. 3G ). Robust circularization of the HAC1 intron by RtcB in trl1∆ cells is facilitated by 5′-OH and 2′,3′-cyclic PO 4 termini created by Ire1 cleavage and the absence of Trl1 end modification activities that could otherwise produce termini (5′-PO 4 or adenylylate; and 2′-PO 4 /3′-OH) incompatible with RtcB ligation. It is noteworthy that circularized intron accumulates to high levels in the absence of tunicamycin ( Fig. 3F , G , lanes 5 and 7), indicating that Ire1 catalyzes a low level of intron excision (and 3′-exon excision ( Fig. 1C )) from HAC1 u during normal growth, leading to the accumulation of stable, circularized introns in the presence of RtcB.
The HAC1 intron and 5′-UTR form an extensive base-pairing interaction that inhibits ribosome initiation (Chapman and Walter, 1997; Di Santo et al., 2016) . Thus, together these data evoke a model in which kinase-mediated decay of the excised HAC1 intron is required for HAC1 s translation, and a failure to degrade HAC1 intron-even when HAC1 s is produced-prevents HAC1 s translation and subsequent expression of stress-responsive genes.
Despite their ability to make HAC1 s , xrn1∆ and trl1∆ (RtcB) cells have growth defects on media containing tunicamycin ( Fig. 3A ) and the relative severity of their defects parallels the accumulation of excised intron in these cells. Cells lacking Xrn1 have a modest growth defect and accumulate linear intron, which can be degraded by other exonucleases ( Fig 3C-E, G ) . In contrast, trl1 ∆ (RtcB) cells have a severe growth defect and accumulate high levels of a stable, circularized intron that is immune to exonucleolytic decay ( Fig. 3F, G ). We believe these findings resolve the mystery of the previously identified "second function" of Trl1 required for UPR activation (Mori et al., 2010) , namely that-in addition to its ligase activity-Trl1 initiates kinase-mediated decay of the excised HAC1 intron, relieving its repressive effect on HAC1 s and activating translation.
Incompletely processed HAC1 s mRNA is endonucleolytically cleaved and degraded.
In addition to the canonical 5′-exon product of 5′-splice site cleavage, a second product uniquely accumulates in tpt1∆ and tpt1∆ ski2∆ cells that is~50 nt shorter than full-length 5′-exon ( Fig. 4A , lanes 4 and 8). Expression of a catalytically inactive form of Tpt1 (Tpt1-R138A, (Sawaya et al., 2005) ) in tpt1 ∆ cells failed to rescue this defect ( Fig. 4B ), affirming that the catalytic activity of Tpt1 is required to prevent accumulation of the shorter 5′-exon fragment. A corresponding elongated 3′-exon fragment accumulates in tpt1 ∆, and more intensely in tpt1 ∆ xrn1∆ cells, indicating it is degraded by Xrn1 ( Fig. 4C-E ). The elongated 3′-exon is specifically detected using a northern probe with a sequence complementary to the distal 3′-end of the 5′-exon ( Fig. 4C, D ) , indicating that a portion of the 5′-exon is responsible for the increased size of this decay intermediate. Moreover, a fragment of similar size hybridizes to a probe for the 3′-exon, suggesting that the sequence derived from 5′-exon is linked to the 3′-exon ( Fig. 4E );
together these data indicate that HAC1 s is cleaved upstream of the 2′-phosphorylated ligation junction in tpt1∆ cells, and these products are degraded by both Xrn1 and the cytoplasmic exosome.
To determine whether HAC1 s sequence is sufficient for cleavage, we expressed plasmid-encoded HAC1 u and HAC1 s in hac1 ∆ cells to identify HAC1 splicing intermediates. We performed the analysis on trl1 ∆ cells, reasoning that if HAC1 s sequence were sufficient to cause cleavage, we would expect an accumulation of 3′-exon in cells unable to ligate or degrade the products by kinase-mediated decay. Tunicamycin treatment of trl1∆ hac1∆ cells expressing HAC1 u caused Ire1-mediated cleavage and accumulation of cleaved 3′-exon ( Fig. 4F , lane 2).
However, we found that full length HAC1 s was the only product produced in the trl1∆ hac1∆ cells in the presence and absence of tunicamycin ( Fig. 4F , lanes 3 and 4) , indicating that the HAC1 s transcript is not sufficient to recapitulate the secondary cleavage, and that HAC1 u must be cleaved and ligated to produce the 2′-phosphorylated HAC1 s cleavage substrate.
To further characterize this secondary cleavage product, we determined the 5′ end of the elongated 3′-exon. We analyzed the 5′-ends of cleaved 3′-exon by primer extension and found that cleaved 3′-exon was barely detectable in wild-type cells upon tunicamycin addition, whereas 3′-exon accumulated in trl1∆ cells due to a lack of kinase-mediated decay ( Fig. 5A , lanes 2 and 8). In tpt1∆ cells treated with tunicamycin, two products accumulated upon tunicamycin addition: a product consistent with canonical length 3′-exon and a small amount of elongated 3′-exon ( Fig. 5A , lane 4) . The elongated product accumulated in tpt1∆ xrn1∆ cells, again indicating it is degraded by Xrn1 ( Fig. 5A , lane 6) . To test this prediction, we measured the susceptibility of 3′-exon fragments to treatment in vitro with recombinant Xrn1 (rXrn1/TEX).
As expected, fragments from xrn1 ∆ cells were degraded by rXrn1 ( Fig. 5B , lanes 6 and 8), establishing that they have 5′-PO 4 termini, whereas 3′-exon fragments from trl1∆ cells were resistant to rXrn1 degradation ( Fig. 5B , lanes 3 and 4) , indicating that they have 5′-OH termini.
The instructive findings came from examining 3′-exon accumulation in tpt1 ∆ cells. The 3′-exon fragment of canonical length that accumulates in tpt1 ∆ cells was resistant to rXrn1 treatment ( Fig. 5B , lanes 11 and 12), while the elongated fragment of 3′-exon is susceptible to rXrn1 treatment ( Fig. 5B , lanes 15 and 16). These observations indicate that 3′ product of secondary cleavage of HAC1 s is a substrate of Xrn1 in vivo and in vitro , raising the possibility that it may also be a substrate of kinase-mediated decay, depending on the chemistry of the endoribonuclease that generates the secondary cleavage. We propose these products are created via two steps: ( i ) HAC1 s is cleaved~50 nt upstream of the 2′-phosphorylated ligation junction; ( ii ) Xrn1 partially degrades the intermediate fragment to the site of 2′-phosphorylation, which inhibits further degradation ( Fig. 5C ). Under this model, the 3′-exon fragment that accumulates in tpt1∆ cells has both 5′-PO 4 and 2′-PO 4 moieties at its first position, which inhibits Xrn1-mediated decay in vivo and in vitro ( Fig. 1C; 4D; 5A, B ).
The accumulation of HAC1 decay intermediates in tpt1∆ cells over time further supports a model of HAC1 s cleavage by Ire1. In tpt1∆ cells, the accumulation of secondary cleavage product coincides with the increase in production of HAC1 s at 20 minutes ( Fig. 6 ). In tpt1∆ cells, cleaved HAC1 3′-exon is present at low levels at steady state and accumulates over the course of two hours upon tunicamycin treatment ( Fig. 6A ). HAC1 s is also generated in tpt1∆ cells, but at significantly reduced levels compared to wild-type ( Fig. 6A , compare lanes 6 and 8). It is also notable that tpt1 ∆ xrn1 ∆ cells ( Fig. 6B ) and tpt1 ∆ ski2 ∆ cells ( Fig. 6D ) accumulate more spliced HAC1 s than tpt1 ∆ cells ( Fig. 6A, 6C ), suggesting that some HAC1 s molecules or splicing intermediates in tpt1∆ cells are degraded, possibly because they contain 2′-PO 4 moieties. At all time points, tpt1 ∆ cells contain more free 3′-exon than HAC1 s , a ratio opposite to wild-type cells ( Fig. 6A ), indicating that that 3′-exon cleaved from HAC1 u accumulates as a result of partial decay of 5′-and 2′-phosphorylated HAC1 s . The augmented accumulation of 3′-exon in tpt1 ∆ cells is also observed in the primer extension analysis (Fig. 5A) , and the Xrn1's in vitro ability to only partially degrade elongated HAC1 3′-exon from tpt1 ∆ xrn1 ∆ cells, and inability to degrade canonical 3′-exon from tpt1 ∆ cells, indicates that the accumulation of free HAC1 3′-exon is likely caused primarily by blocked 5′→3′ degradation.
DISCUSSION
Many different regulatory events impinge on HAC1 mRNA to control its localization and processing. It has been assumed that cleavage of HAC1 u by Ire1 is the rate-limiting step for UPR activation. Counter to this view, we found that decay of HAC1 splicing intermediates is required for both UPR activation and suppression. We found several examples wherein "kinase-mediated decay" (KMD) degrades HAC1 splicing intermediates containing 5′-OH termini by sequential 5′-phosphorylation and 5′-phosphate-dependent 5′→3′ exonucleolytic degradation ( Fig. 7 ).
We propose that after 3′-splice site cleavage by Ire1, the Trl1 5′-kinase domain associates with and phosphorylates the 5′-OH of the 3′-exon product ( Fig. 7 ) . Dissociation of the Trl1 kinase active site from the 5′-PO 4 product then enables a competition between reassociation of Trl1 (now its adenylyltransferase/ligase domain) to catalyze ligation-or Xrn1 to catalyze degradation. In some circumstances, this balance is tipped to favor ligation even in the absence of overt UPR stimulation: a lack of decay in xrn1∆ cells favors ligation, whereas the lack of 5′-kinase activity in trl1∆ ( RtcB ) cells renders Xrn1 decay irrelevant ( Fig. 2F ). Xrn1 is abundant in budding yeast (Ghaemmaghami et al., 2003) , which may efficiently suppress the UPR under normal conditions by degrading spuriously cleaved HAC1 3′-exon intermediates.
Regulation of the ligation step of HAC1 s splicing makes intuitive sense because it is the last opportunity to act during splicing; once ligated, HAC1 s is again protected by a 7-methylguanosine cap and a poly-(A) tail. Spurious HAC1 splicing was previously reported in trl1∆ cells expressing the tRNA ligase from Arabidopsis thaliana (Mori et al., 2010) . It is noteworthy that there are mechanistic differences between the tRNA ligases of A. thaliana and another yeast ( K. lactis ) (Remus and Shuman, 2014) , suggesting that these differences could impact the balance between kinase-mediated decay and ligation in budding yeast expressing plant RNA ligase.
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We also found that excised HAC1 intron is a substrate of kinase-mediated decay ( Fig.   3 ). Indeed, we believe that phosphorylation of HAC1 intron by Trl1 to promote kinase-mediated decay is the previously proposed "second role" of Trl1 ligase in activating HAC1 translation independent of ligation (Mori et al., 2010) . In this previous study, excised and circularized HAC1
intron was found to remain associated with HAC1 s , inhibiting translation. Kinase-mediated decay of excised intron therefore likely relieves the long-range base-pairing interaction that prevents HAC1 s translation (Chapman and Walter, 1997; Di Santo et al., 2016; Rüegsegger et al., 2001) , explaining how HAC1 s can accumulate without concomitant UPR activation. This second layer of control over HAC1 s translation by KMD adds another failsafe mechanism to prevent its translation and unintentional UPR activation.
Previous examples of kinase-mediated decay of bacterial mRNAs (Durand et al., 2012) , eukaryal tRNA introns (Wu and Hopper, 2014) , and ribosomal RNA processing intermediates (Gasse et al., 2015) suggest that this mode of decay may be widespread. Coupling of RNA 5′-kinase and 5′→3′ exonucleolytic decay activities in the context of kinase-mediated decay might regulate the UPR in other organisms. Splicing of Xbp-1 mRNA in metazoans (the functional homolog of HAC1 ) is catalyzed by Ire1-mediated removal of an intron and ligation by RtcB RNA ligase (Kosmaczewski et al., 2014; Lu et al., 2014) . Fundamental differences in the chemistry of RNA ligation between fungal and metazoan ligases suggest that Xbp-1 may be subject to a biochemically distinct mode of regulation. Because RtcB depends on 5′-OH and 3′-PO 4 termini for catalysis (Chakravarty et al., 2012) , activities that remodel 5′-OH RNA termini could divert Ire1-generated 5′-OH splicing intermediates from productive ligation. For example, an RNA 5′-kinase ( e . g ., Clp1) may phosphorylate the 3′-exon product of Xbp-1 cleavage, simultaneously inhibiting ligation by RtcB and promoting its degradation by a 5′-phosphate-dependent exoribonuclease to limit UPR activation. In this vein, it is noteworthy that kinase-inactivating mutations in Clp1 cause neurodevelopmental defects and neuronal dysfunction in humans, mice, and zebrafish (Hanada et al., 2013; Karaca et al., 2014; Schaffer et al., 2014) , possibly due to chronic UPR activation in neural tissues (Clayton and Popko, 2016) . Xrn1 degrades mRNA fragments generated during metazoan Regulated Ire1-dependent Degradation (RIDD) (Hollien and Weissman, 2006) ; however, it is not known how these 5′-OH cleavage products of Ire1 are phosphorylated for Xrn1-mediated decay. The RNA 5′-kinase Clp1 (Weitzer and Martinez, 2007) and polynucleotide kinase Nol9 (Heindl and Martinez, 2010) are candidates for this activity, though neither are known to phosphorylate mRNA decay intermediates.
While 5′→3′ decay plays a major role in UPR regulation, we found little evidence for UPR regulation by 3′→5′ decay activity. As shown previously (Schwer et al., 2004 ) , the exposed 3′-end of cleaved HAC1 5′-exon is a substrate for 3′→5′ decay ( Fig. 4 ). But while excised HAC1
intron is stabilized in ski2∆ cells lacking cytosolic 3′→5′ decay ( Fig. 3H ) , their growth is unaffected by tunicamycin ( Fig. 1B ), indicating that 3′→5′ decay of the excised intron does not contribute substantially to intron-mediated HAC1 s repression.
We also found evidence that Ire1 cleaves incompletely processed HAC1 s mRNA, which is ligated but contains an internal 2′-PO 4 moiety. Cleavage of HAC1 s leads to 5′ and 3′ fragments that are degraded; however, the 3′-fragment is only partially degraded by kinase-mediated decay, producing a 5′-and 2′-phosphorylated molecule that cannot be degraded by Xrn1.
Consistent with these findings, a recent study also showed that an RNA with an internal 2′-phosphate group is protected from 3′→5′ decay by E. coli PNPase in vitro (Munir et al., 2018) ; those and our results together indicate that site-specific installation of a 2′-PO 4 is an effective strategy to protect an RNA from complete exonucleolytic degradation in vivo or in vitro .
Decay intermediates produced from incompletely processed, 2´-phosphorylated HAC1 s have not been previously observed and suggest a plausible regulatory role for Tpt1 in regulating HAC1 s fate.
We have yet to determine the impact of 2′-phosphorylation on HAC1 s translation, but given that tpt1∆ cells grow on tunicamycin ( Fig. 1B & (Cherry et al., 2018) ) and activate KAR2 gene expression ( Fig. 3B ), it is likely that some Hac1 protein is produced from 2′-PO 4 HAC1 s . It also remains to be determined how and why incompletely processed HAC1 s is cleaved. Insofar as the HAC1 s cleavage substrate is initially produced by tunicamycin-dependent Ire1 cleavage and ligation, we surmise that Ire1 incises ligated, 2′-phosphorylated HAC1 s upstream of the original ligation junction, yielding smaller 5′-exon and larger 3′-exon fragments. Formally, we cannot currently rule out the possibility that another endonuclease catalyzes HAC1 s cleavage; however, Ire1 is the only endoribonuclease known to site-specifically incise HAC1 mRNA, and the elongated 3′-exon is degraded by kinase-mediated decay ( Fig. 5C ), confirming that the incision product is a 5′-OH RNA and consistent with Ire1 cleavage. We note that ire1 ∆ mutants are unable to initiate processing of HAC1 u and therefore do not make HAC1 s in the first place (Sidrauski and Walter, 1997) , precluding direct analysis of HAC1 s cleavage in ire1 ∆ mutants.
We showed that the 2′-PO 4 is required for cleavage, as expression of "pre-spliced" HAC1 s does not lead to cleavage ( Fig. 4E ). It is possible that the presence of a 2′-PO 4 in the context of a composite Ire1 splice site ( i . e ., formed from two halves of the original 5′-and 3′-splice sites (Hooks and Griffiths-Jones, 2011; Sidrauski and Walter, 1997 ) ) on HAC1 s is recognized by Ire1, but because a 2′-OH is the nucleophile for transesterification by metal-independent Ire1 (Gonzalez et al., 1999) , the 2′-PO 4 inhibits the chemical step of incision.
This model also provides a plausible mechanism to explain how Ire1 incises a neighboring, non-canonical site. We propose that a failure of Ire1 to release 2′-phosphorylated HAC1 s would enable the active site of a nearby Ire1 molecule-in the context of its activated, oligomeric form ) -to catalyze site-specific incision at the second, upstream site. Our results also raise the question of why Ire1 would cut incompletely processed HAC1 s . Here, cleavage of incompletely processed (ligated, but 2´-phosphorylated) HAC1 s could be a means to inactivate HAC1 s after prolonged stimulation to attenuate the UPR (Chawla et al., 2011; Rubio et al., 2011) .
MATERIALS AND METHODS

Yeast strains and plasmids
Yeast strains and sources used in this study are listed in Table S3 . Plasmids were created as indicated in Table S3 .
Cell culture and RNA preparation
Single colonies were inoculated in drop-out media supplemented with relevant amino acids and incubated at 30°C overnight with rotation. Cultures were diluted to an OD 600 of 0.2 in yeast-extract, peptone, dextrose (YPD) media, and UPR induction was carried out when yeast were goring at mid-log phase with a 2 hour treatment (unless otherwise indicated) with tunicamycin (final concentration of 2.5 µg/mL, Sigma-Aldrich) or DMSO mock treatment. Cells were harvested by centrifugation and total RNA was isolated by hot acid phenol extraction. For RT-PCR and RT-qPCR experiments, total RNA was treated with TURBO DNase (2 U, Ambion)
to degrade contaminating genomic DNA.
RT-PCR/qPCR
DNase-treated RNA was reverse transcribed with 200 U of SuperScript III reverse transcriptase (Invitrogen) using a gene-specific reverse primer ( Table 2 ). Products analyzed on a 1.5% agarose TBE gel, stained with 1x GelRed (Sigma) and imaged with a Bio Rad GelDoc.
Densitometry was performed with Bio-Rad Image Analysis software and splicing quantifications were computed and visualized in R using ggplot2 and cowplot R Packages. Quantitative PCR (qPCR) for KAR2 was also performed on cDNA as generated above, and assayed for KAR2
and PGK1 using Sso Advanced Universal SYBR Green Supermix (Bio Rad) and cycled on a Bio Rad C1000 384-well thermal cycler and plate reader. Output C t values were analyzed in Microsoft Excel and plotted in R using ggplot2 and cowplot R Packages.
Primer Extension
Primers specific for HAC1 mRNA and U6 snRNA were PAGE-purified and ethanol precipitated.
Oligonucleotide primers were 5′-end-labeled with PNK (Enzymatics) and γ-32 P-ATP (Perkin Elmer) and purified with Sephadex G-25 spin columns (GE Healthcare resin, Thermo empty columns). Radiolabeled primers and total RNA (15 µg) were heated to 65°C for 5 minutes and cooled to 42°C. SuperScript III reverse transcriptase (200 U, Invitrogen) was added and reverse transcription reactions were run with a final concentration of 500 µM dNTPs. Primers were extended for 30 minutes at 42°C, 15 minutes at 45°C, and 15 minutes at 50°C. SuperScript III RT was inactivated by heating for 20 minutes at 75°C. RNA was destroyed with in 10 mM NaOH at 90°C for 3 minutes and neutralized with HCl. Formamide loading dye was added and products were run on a 8% acrylamide TBE 7M Urea gel. Gels were dried (Bio Rad) and exposed on a phosphor-imager screen and imaged on a Typhoon 9400 (GE Healthcare).
Northern blotting
Total RNA (3 µg) was electrophoresed on 6% acrylamide TBE 7M urea gels and transferred to nylon membrane (Hybond N+, GE) by electroblotting. Membranes were UV-crosslinked (254 nm, 120 mJ dose), blocked in ULTRAhyb-Oligo Buffer (Ambion), and incubated with 5′-32 P-labeled oligonucleotide probes ( Table S2 ) in ULTRAhyb-Oligo at 42°C for 18 hours.
Membranes were washed with 2X SSC/0.5% SDS washing buffer two time for 30 minutes each, exposed on a phosphor-imager storage screen, and imaged on a Typhoon 9400 (GE Healthcare). Membranes were stripped of original probe with 3 washes in stripping buffer (2% SDS) at 80°C for 30 minutes per wash. Membranes were re-blocked and probed a second time for the loading control, SCR1 (Table S2 ). C. HAC1 processing in RNA repair and decay mutants (3′-exon probe). HAC1 u cleavage and ligation was analyzed in mutants of TRL1 RNA ligase and TPT1 2′-phosphotransferase by acrylamide northern blotting using a probe to the HAC1 3′-exon. Diagrams of HAC1 u , HAC1 s , and HAC1 splicing intermediates are drawn next to predominant bands (see Table 1 for descriptions and sizes of all annotations). HAC1 u is cleaved and ligated to produce HAC1 s in wild-type cells (lanes 1 & 2). Intron/3′-exon and 3′-exon splicing intermediates accumulate in C . Excised HAC1 intron is stabilized in xrn1 ∆ and trl1 ∆ cells. Northern blot analysis using a probe to HAC1 intron reveals that excised intron (252 nt) and partially-degraded intron intermediates accumulate in xrn1 ∆ cells. Ligase-delete cells ( trl1 ∆) also accumulate of intron as uniformly sized 252 nt product. In xrn1 ∆ and trl1 ∆ cells, intron accumulates in the absence tunicamycin.
FIGURE LEGENDS
D. Catalytic activity of Trl1 5′-kinase is required for 5′→3′ decay of excised HAC1 intron.
Northern blot analysis using a probe to HAC1 intron shows that a missense mutant in the 5′-kinase domain of Trl1 ( trl1-D425N) C. The shortened 5′-exon is missing a portion of its 3′-end. A northern blot was probed with 5′-exon probe 2, which hybridizes to the 3′-most 30 nt of HAC1 5′-exon (see diagram in A).
Compared to the blot in A , the shortened 5′-exon species is absent (lanes 4 and 8) and instead the probe detects smaller bands consistent with the length of the elongated 3′-exon (see region of enhanced contrast).
D.
A lengthened form of 3′-exon accumulates in tpt1 ∆ cells. Total RNA from tpt1 ∆ and xrn1 ∆ cells was analyzed by northern blot with 5′-exon probe 2, a probe that anneals to the 3′-most 30 nt of HAC1 5′-exon. C and D share the same band interpretation key, so dashed lines have been drawn across to illustrate the different positions of typical 3′-exon (474 nt) and elongated 3′-exon (524 nt).
E. The elongated 3′-exon from tpt1 ∆ cells co-migrates and co-hybridizes with 5′-exon probe 2 (see C). Stripping the blot from C and re-hybridizing it with HAC1 3′-exon probe detects the same, elongated band(s) as in the 5′-exon probe 2 blot (lane 8), as well as HAC1 3′-exon bands of typical length.
F. Expression of "pre-spliced" HAC1 s is not sufficient to promote cleavage. Total RNA from trl1 ∆ hac1 ∆ cells expressing HAC1 u and HAC1 s from a plasmid was analyzed by northern blot with a 3′-exon probe. Full length HAC1 u expressed from this construct is cleaved upon tunicamycin addition (lane 2) Expression of "pre-spliced" HAC1 s yields a single product with no decay intermediates (lanes 3 and 4) , indicating that "pre-spliced" HAC1 s -which was not produced by ligation and therefore lacks a 2′-phosphate-is not sufficient to recapitulate the cleavage found in tpt1 ∆ cells. Sizes of HAC1 processing intermediates are predicted from strand-specific RNA sequencing data (Levin et al., 2010) mapped to the sacCer1 genome. *Size does not include poly(A) tail. 
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